 | • レポートコード：MRC2-11QY11378 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は循環腫瘍細胞（CTC）のグローバル市場について調査・分析したレポートです。種類別（CTCエンリッチメント、CTC検出、CTC分析）市場規模、用途別（乳がん、前立腺がん、大腸がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別循環腫瘍細胞（CTC）の競争状況、市場シェア ・世界の循環腫瘍細胞（CTC）市場：種類別市場規模 2015年-2020年（CTCエンリッチメント、CTC検出、CTC分析） ・世界の循環腫瘍細胞（CTC）市場：種類別市場規模予測 2021年-2026年（CTCエンリッチメント、CTC検出、CTC分析） ・世界の循環腫瘍細胞（CTC）市場：用途別市場規模 2015年-2020年（乳がん、前立腺がん、大腸がん、その他） ・世界の循環腫瘍細胞（CTC）市場：用途別市場規模予測 2021年-2026年（乳がん、前立腺がん、大腸がん、その他） ・北米の循環腫瘍細胞（CTC）市場分析：米国、カナダ ・ヨーロッパの循環腫瘍細胞（CTC）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの循環腫瘍細胞（CTC）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の循環腫瘍細胞（CTC）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの循環腫瘍細胞（CTC）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Menarini-Silicon Biosystems、Qiagen（Adnagen）、Clearbridge Biomedics、Celsee、Fluidigm、ApoCell、Greiner Bio-one GmbH、Advanced Cell Diagnostics、Aviva Biosciences、Fluxion Biosciences、Sysmex Corporation、Epic Sciences、Cynvenio、CytoTrack、Ikonisys、Vortex BioSciences、Gilupi、Biocept、ScreenCell、ANGLE ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.
Market Analysis and Insights: Global Circulating Tumor Cell Market
The global Circulating Tumor Cell market size is projected to reach US$ 6984.4 million by 2026, from US$ 6202.8 million in 2020, at a CAGR of 12.0%% during 2021-2026.
Global Circulating Tumor Cell Scope and Market Size
Circulating Tumor Cell market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Menarini-Silicon Biosystems
Qiagen（Adnagen）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one GmbH
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex Corporation
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Market segment by Type, the product can be split into
CTC Enrichment
CTC Detection
CTC Analysis
Market segment by Application, split into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cell Revenue
1.4 Market by Type
1.4.1 Global Circulating Tumor Cell Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CTC Enrichment
1.4.3 CTC Detection
1.4.4 CTC Analysis
1.5 Market by Application
1.5.1 Global Circulating Tumor Cell Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer
1.5.3 Prostate Cancer
1.5.4 Colorectal Cancer
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell Market Perspective (2015-2026)
2.2 Global Circulating Tumor Cell Growth Trends by Regions
2.2.1 Circulating Tumor Cell Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cell Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cell Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Circulating Tumor Cell Market Growth Strategy
2.3.6 Primary Interviews with Key Circulating Tumor Cell Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell Players by Market Size
3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2015-2020)
3.1.3 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cell Market Concentration Ratio
3.2.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2019
3.3 Circulating Tumor Cell Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cell Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cell Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Circulating Tumor Cell Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Circulating Tumor Cell Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Tumor Cell Market Size (2015-2020)
6.2 Circulating Tumor Cell Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cell Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cell Market Size by Application (2015-2020)
7 Europe
7.1 Europe Circulating Tumor Cell Market Size (2015-2020)
7.2 Circulating Tumor Cell Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cell Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cell Market Size by Application (2015-2020)
8 China
8.1 China Circulating Tumor Cell Market Size (2015-2020)
8.2 Circulating Tumor Cell Key Players in China (2019-2020)
8.3 China Circulating Tumor Cell Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cell Market Size by Application (2015-2020)
9 Japan
9.1 Japan Circulating Tumor Cell Market Size (2015-2020)
9.2 Circulating Tumor Cell Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cell Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cell Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cell Market Size (2015-2020)
10.2 Circulating Tumor Cell Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Tumor Cell Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Tumor Cell Market Size by Application (2015-2020)
11 India
11.1 India Circulating Tumor Cell Market Size (2015-2020)
11.2 Circulating Tumor Cell Key Players in India (2019-2020)
11.3 India Circulating Tumor Cell Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cell Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Circulating Tumor Cell Market Size (2015-2020)
12.2 Circulating Tumor Cell Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Tumor Cell Market Size by Type (2015-2020)
12.4 Central & South America Circulating Tumor Cell Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Menarini-Silicon Biosystems
13.1.1 Menarini-Silicon Biosystems Company Details
13.1.2 Menarini-Silicon Biosystems Business Overview
13.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction
13.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2015-2020))
13.1.5 Menarini-Silicon Biosystems Recent Development
13.2 Qiagen（Adnagen）
13.2.1 Qiagen（Adnagen） Company Details
13.2.2 Qiagen（Adnagen） Business Overview
13.2.3 Qiagen（Adnagen） Circulating Tumor Cell Introduction
13.2.4 Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2015-2020)
13.2.5 Qiagen（Adnagen） Recent Development
13.3 Clearbridge Biomedics
13.3.1 Clearbridge Biomedics Company Details
13.3.2 Clearbridge Biomedics Business Overview
13.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction
13.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2015-2020)
13.3.5 Clearbridge Biomedics Recent Development
13.4 Celsee
13.4.1 Celsee Company Details
13.4.2 Celsee Business Overview
13.4.3 Celsee Circulating Tumor Cell Introduction
13.4.4 Celsee Revenue in Circulating Tumor Cell Business (2015-2020)
13.4.5 Celsee Recent Development
13.5 Fluidigm
13.5.1 Fluidigm Company Details
13.5.2 Fluidigm Business Overview
13.5.3 Fluidigm Circulating Tumor Cell Introduction
13.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2015-2020)
13.5.5 Fluidigm Recent Development
13.6 ApoCell
13.6.1 ApoCell Company Details
13.6.2 ApoCell Business Overview
13.6.3 ApoCell Circulating Tumor Cell Introduction
13.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2015-2020)
13.6.5 ApoCell Recent Development
13.7 Greiner Bio-one GmbH
13.7.1 Greiner Bio-one GmbH Company Details
13.7.2 Greiner Bio-one GmbH Business Overview
13.7.3 Greiner Bio-one GmbH Circulating Tumor Cell Introduction
13.7.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2015-2020)
13.7.5 Greiner Bio-one GmbH Recent Development
13.8 Advanced Cell Diagnostics
13.8.1 Advanced Cell Diagnostics Company Details
13.8.2 Advanced Cell Diagnostics Business Overview
13.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction
13.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2015-2020)
13.8.5 Advanced Cell Diagnostics Recent Development
13.9 Aviva Biosciences
13.9.1 Aviva Biosciences Company Details
13.9.2 Aviva Biosciences Business Overview
13.9.3 Aviva Biosciences Circulating Tumor Cell Introduction
13.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2015-2020)
13.9.5 Aviva Biosciences Recent Development
13.10 Fluxion Biosciences
13.10.1 Fluxion Biosciences Company Details
13.10.2 Fluxion Biosciences Business Overview
13.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction
13.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2015-2020)
13.10.5 Fluxion Biosciences Recent Development
13.11 Sysmex Corporation
10.11.1 Sysmex Corporation Company Details
10.11.2 Sysmex Corporation Business Overview
10.11.3 Sysmex Corporation Circulating Tumor Cell Introduction
10.11.4 Sysmex Corporation Revenue in Circulating Tumor Cell Business (2015-2020)
10.11.5 Sysmex Corporation Recent Development
13.12 Epic Sciences
10.12.1 Epic Sciences Company Details
10.12.2 Epic Sciences Business Overview
10.12.3 Epic Sciences Circulating Tumor Cell Introduction
10.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2015-2020)
10.12.5 Epic Sciences Recent Development
13.13 Cynvenio
10.13.1 Cynvenio Company Details
10.13.2 Cynvenio Business Overview
10.13.3 Cynvenio Circulating Tumor Cell Introduction
10.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2015-2020)
10.13.5 Cynvenio Recent Development
13.14 CytoTrack
10.14.1 CytoTrack Company Details
10.14.2 CytoTrack Business Overview
10.14.3 CytoTrack Circulating Tumor Cell Introduction
10.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2015-2020)
10.14.5 CytoTrack Recent Development
13.15 Ikonisys
10.15.1 Ikonisys Company Details
10.15.2 Ikonisys Business Overview
10.15.3 Ikonisys Circulating Tumor Cell Introduction
10.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2015-2020)
10.15.5 Ikonisys Recent Development
13.16 Vortex BioSciences
10.16.1 Vortex BioSciences Company Details
10.16.2 Vortex BioSciences Business Overview
10.16.3 Vortex BioSciences Circulating Tumor Cell Introduction
10.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2015-2020)
10.16.5 Vortex BioSciences Recent Development
13.17 Gilupi
10.17.1 Gilupi Company Details
10.17.2 Gilupi Business Overview
10.17.3 Gilupi Circulating Tumor Cell Introduction
10.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2015-2020)
10.17.5 Gilupi Recent Development
13.18 Biocept
10.18.1 Biocept Company Details
10.18.2 Biocept Business Overview
10.18.3 Biocept Circulating Tumor Cell Introduction
10.18.4 Biocept Revenue in Circulating Tumor Cell Business (2015-2020)
10.18.5 Biocept Recent Development
13.19 ScreenCell
10.19.1 ScreenCell Company Details
10.19.2 ScreenCell Business Overview
10.19.3 ScreenCell Circulating Tumor Cell Introduction
10.19.4 ScreenCell Revenue in Circulating Tumor Cell Business (2015-2020)
10.19.5 ScreenCell Recent Development
13.20 ANGLE
10.20.1 ANGLE Company Details
10.20.2 ANGLE Business Overview
10.20.3 ANGLE Circulating Tumor Cell Introduction
10.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2015-2020)
10.20.5 ANGLE Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Circulating Tumor Cell Key Market Segments
Table 2. Key Players Covered: Ranking by Circulating Tumor Cell Revenue
Table 3. Ranking of Global Top Circulating Tumor Cell Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Circulating Tumor Cell Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CTC Enrichment
Table 6. Key Players of CTC Detection
Table 7. Key Players of CTC Analysis
Table 8. Global Circulating Tumor Cell Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Circulating Tumor Cell Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Circulating Tumor Cell Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Circulating Tumor Cell Market Share by Regions (2015-2020)
Table 12. Global Circulating Tumor Cell Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Circulating Tumor Cell Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Circulating Tumor Cell Market Growth Strategy
Table 18. Main Points Interviewed from Key Circulating Tumor Cell Players
Table 19. Global Circulating Tumor Cell Revenue by Players (2015-2020) (Million US$)
Table 20. Global Circulating Tumor Cell Market Share by Players (2015-2020)
Table 21. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell as of 2019)
Table 22. Global Circulating Tumor Cell by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Circulating Tumor Cell Product Solution and Service
Table 25. Date of Enter into Circulating Tumor Cell Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 28. Global Circulating Tumor Cell Market Size Share by Type (2015-2020)
Table 29. Global Circulating Tumor Cell Revenue Market Share by Type (2021-2026)
Table 30. Global Circulating Tumor Cell Market Size Share by Application (2015-2020)
Table 31. Global Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 32. Global Circulating Tumor Cell Market Size Share by Application (2021-2026)
Table 33. North America Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 35. North America Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 36. North America Circulating Tumor Cell Market Share by Type (2015-2020)
Table 37. North America Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 38. North America Circulating Tumor Cell Market Share by Application (2015-2020)
Table 39. Europe Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 41. Europe Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Circulating Tumor Cell Market Share by Type (2015-2020)
Table 43. Europe Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Circulating Tumor Cell Market Share by Application (2015-2020)
Table 45. China Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 46. China Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 47. China Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 48. China Circulating Tumor Cell Market Share by Type (2015-2020)
Table 49. China Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 50. China Circulating Tumor Cell Market Share by Application (2015-2020)
Table 51. Japan Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 53. Japan Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Circulating Tumor Cell Market Share by Type (2015-2020)
Table 55. Japan Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Circulating Tumor Cell Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 59. Southeast Asia Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Circulating Tumor Cell Market Share by Type (2015-2020)
Table 61. Southeast Asia Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Circulating Tumor Cell Market Share by Application (2015-2020)
Table 63. India Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 64. India Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 65. India Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 66. India Circulating Tumor Cell Market Share by Type (2015-2020)
Table 67. India Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 68. India Circulating Tumor Cell Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Circulating Tumor Cell Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Circulating Tumor Cell Market Share (2019-2020)
Table 71. Central & South America Circulating Tumor Cell Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Circulating Tumor Cell Market Share by Type (2015-2020)
Table 73. Central & South America Circulating Tumor Cell Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Circulating Tumor Cell Market Share by Application (2015-2020)
Table 75. Menarini-Silicon Biosystems Company Details
Table 76. Menarini-Silicon Biosystems Business Overview
Table 77. Menarini-Silicon Biosystems Product
Table 78. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 79. Menarini-Silicon Biosystems Recent Development
Table 80. Qiagen（Adnagen） Company Details
Table 81. Qiagen（Adnagen） Business Overview
Table 82. Qiagen（Adnagen） Product
Table 83. Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 84. Qiagen（Adnagen） Recent Development
Table 85. Clearbridge Biomedics Company Details
Table 86. Clearbridge Biomedics Business Overview
Table 87. Clearbridge Biomedics Product
Table 88. Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 89. Clearbridge Biomedics Recent Development
Table 90. Celsee Company Details
Table 91. Celsee Business Overview
Table 92. Celsee Product
Table 93. Celsee Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 94. Celsee Recent Development
Table 95. Fluidigm Company Details
Table 96. Fluidigm Business Overview
Table 97. Fluidigm Product
Table 98. Fluidigm Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 99. Fluidigm Recent Development
Table 100. ApoCell Company Details
Table 101. ApoCell Business Overview
Table 102. ApoCell Product
Table 103. ApoCell Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 104. ApoCell Recent Development
Table 105. Greiner Bio-one GmbH Company Details
Table 106. Greiner Bio-one GmbH Business Overview
Table 107. Greiner Bio-one GmbH Product
Table 108. Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 109. Greiner Bio-one GmbH Recent Development
Table 110. Advanced Cell Diagnostics Business Overview
Table 111. Advanced Cell Diagnostics Product
Table 112. Advanced Cell Diagnostics Company Details
Table 113. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 114. Advanced Cell Diagnostics Recent Development
Table 115. Aviva Biosciences Company Details
Table 116. Aviva Biosciences Business Overview
Table 117. Aviva Biosciences Product
Table 118. Aviva Biosciences Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 119. Aviva Biosciences Recent Development
Table 120. Fluxion Biosciences Company Details
Table 121. Fluxion Biosciences Business Overview
Table 122. Fluxion Biosciences Product
Table 123. Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 124. Fluxion Biosciences Recent Development
Table 125. Sysmex Corporation Company Details
Table 126. Sysmex Corporation Business Overview
Table 127. Sysmex Corporation Product
Table 128. Sysmex Corporation Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 129. Sysmex Corporation Recent Development
Table 130. Epic Sciences Company Details
Table 131. Epic Sciences Business Overview
Table 132. Epic Sciences Product
Table 133. Epic Sciences Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 134. Epic Sciences Recent Development
Table 135. Cynvenio Company Details
Table 136. Cynvenio Business Overview
Table 137. Cynvenio Product
Table 138. Cynvenio Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 139. Cynvenio Recent Development
Table 140. CytoTrack Company Details
Table 141. CytoTrack Business Overview
Table 142. CytoTrack Product
Table 143. CytoTrack Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 144. CytoTrack Recent Development
Table 145. Ikonisys Company Details
Table 146. Ikonisys Business Overview
Table 147. Ikonisys Product
Table 148. Ikonisys Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 149. Ikonisys Recent Development
Table 150. Vortex BioSciences Company Details
Table 151. Vortex BioSciences Business Overview
Table 152. Vortex BioSciences Product
Table 153. Vortex BioSciences Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 154. Vortex BioSciences Recent Development
Table 155. Gilupi Company Details
Table 156. Gilupi Business Overview
Table 157. Gilupi Product
Table 158. Gilupi Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 159. Gilupi Recent Development
Table 160. Biocept Company Details
Table 161. Biocept Business Overview
Table 162. Biocept Product
Table 163. Biocept Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 164. Biocept Recent Development
Table 165. ScreenCell Company Details
Table 166. ScreenCell Business Overview
Table 167. ScreenCell Product
Table 168. ScreenCell Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 169. ScreenCell Recent Development
Table 170. ANGLE Company Details
Table 171. ANGLE Business Overview
Table 172. ANGLE Product
Table 173. ANGLE Revenue in Circulating Tumor Cell Business (2015-2020) (Million US$)
Table 174. ANGLE Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell Market Share by Type: 2020 VS 2026
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cell Market Share by Application: 2020 VS 2026
Figure 6. Breast Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Circulating Tumor Cell Report Years Considered
Figure 11. Global Circulating Tumor Cell Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Circulating Tumor Cell Market Share by Regions: 2020 VS 2026
Figure 13. Global Circulating Tumor Cell Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Circulating Tumor Cell Market Share by Players in 2019
Figure 16. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Revenue in 2019
Figure 18. North America Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Circulating Tumor Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…- 循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker for Liquid Bi…
- 乳癌リキッドバイオプシーの世界市場（～2026年） Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. Market Analysis and Insights: Global Breast Cancer …
- 腫瘍バイオマーカー検査の世界市場（～2026年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Biomarker Test Scope and Market Size Tumor Biomarker Test market is…